HomeLSL • CVE
add
LSL Pharma Group Inc
Nakaraang pagsara
$0.38
Sakop ng araw
$0.39 - $0.39
Sakop ng taon
$0.29 - $0.50
Market cap
44.46M CAD
Average na Volume
39.82K
P/E ratio
13.36
Dividend yield
-
Primary exchange
CVE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 5.38M | 55.68% |
Gastos sa pagpapatakbo | 1.26M | 37.12% |
Net na kita | 4.50M | 454.25% |
Net profit margin | 83.55 | 327.53% |
Kita sa bawat share | — | — |
EBITDA | 481.00K | 160.35% |
Aktuwal na % ng binabayarang buwis | 1.10% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 296.00K | 3,600.00% |
Kabuuang asset | 53.51M | 73.17% |
Kabuuang sagutin | 28.62M | 28.65% |
Kabuuang equity | 24.89M | — |
Natitirang share | 115.53M | — |
Presyo para makapag-book | 1.70 | — |
Return on assets | 1.18% | — |
Return on capital | 1.33% | — |
Cash Flow
Net change in cash
| (CAD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 4.50M | 454.25% |
Cash mula sa mga operasyon | 452.00K | 3,376.92% |
Cash mula sa pag-invest | -2.14M | -393.53% |
Cash mula sa financing | 1.82M | 296.72% |
Net change in cash | 132.00K | 247.37% |
Malayang cash flow | -2.98M | -30.11% |
Tungkol
Itinatag
2010
Website
Mga Empleyado
186
